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Background: Pollen exposure of allergic subjects with asthma causes increased nitric oxide
(NO) in exhaled air (FENO) suggestive of increased airway inflammation. It is, however, unclear
to what extent NO production in peripheral airways and alveoli are involved.
Objectives: The aim of the present investigation was to analyze the relationship between cen-
tral and peripheral components of FENO to clarify the distribution of pollen induced inflamma-
tion in asthma.
Subjects and methods: 13 pollen allergic non-smoking subjects with mild-intermittent asthma
and 12 healthy non-smoking control subjects were examined with spirometry and FENO at
flows between 50 and 270 mL/s during and out of pollen season.
Results: Spirometry was normal and unaffected by season in subjects with asthma as well as con-
trols.Outof season subjectswith asthmahad significantlyhigher FENO, elevatedairwayproduction
(Ja´wNO) and preacinar/acinar production (CANO) than controls. Pollen exposure resulted in signif-
icantly increased FENO and Ja´wNO but not CANO. FENO among controls were not affected by sea-
son. Individual results showed, however, that CANO increased substantially in a few subjects with
asthma. The increasedCANO in subjectswith asthmamay beexplained by increasedNOproduction
in preacinar/acinar airways and back diffusion towards the alveoli.
Conclusions: The findings may indicate that subjects with allergic asthma have airway inflamma-
tion without alveolar involvement outside the pollen season and pollen exposure causes a further
increase of airway inflammation and in a few subjects obstruction of intra acinar airways causing
impeded back diffusion. Increased NO production in central airways, unassociated with airway
obstruction could be an alternative explanation. These effects were not disclosed by spirometry.
ª 2014 Elsevier Ltd. All rights reserved.l and Environmental Medicine, Sahlgrenska University Hospital, SE-40530 Gothenburg, Sweden.
mm.gu.se (A.-C. Olin).
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1278 B. Bake et al.IntroductionDuring natural pollen exposure exhaled nitric oxide (FENO)
is increased compared to out of season in subjects with
pollen allergic asthma and allergic rhinitis [1e8]. FENO
originates from central and peripheral airways and alveoli
[9,10] but the origin of the increased FENO during pollen
season is unclear.
By measuring FENO at various constant exhalation flows
between 50 and 300 mL/s a central (Ja´wNO) and a peripheral
(CANO) NO source can be estimated according to the so called
“slope intercept method” [9e11]. FENO obtained at an
exhalation flow of 50 mL/s (FENO0.05) has been shown to be
intimately related to Ja´wNO (R2Z 0.99) among normal sub-
jects and subjects with asthma with normal spirometry [12]
indicating that Ja´wNO and FENO0.05 carry the same informa-
tion. The so called “central” source is, however, a composite
of NO produced by central conducting airways and preacinar/
acinar airways. About half of FENO0.05 originates from the
preacinar region in normal subjects according to Kerckx et al.
[13,14]. At this very peripheral zone NO transport by diffusion
becomes importantbecauseof the largeairwaycross sectional
area [15] and the concentration gradient with lower concen-
tration towards the alveoli. During exhalation NO is trans-
ported by bulk flow towards the mouth whereas the NO
transport by diffusion is in the opposite direction towards the
alveolar end. At the onset of the acinus the airway cross
sectional area is about 300 cm [2] and increases drastically
towards the periphery [15]. NO transport by bulk flow and by
diffusion in the opposite direction becomes equal approxi-
mately at the level of the onset of the acinus i.e. about 0.6 cm
fromthealveolarend [16]. The importanceofbackdiffusionof
NO towards the alveolar end during exhalation is evidenced
also by results frombreathing amixture of 80% helium and 20%
oxygen when NO diffusion is increased 2.3 fold. Then FENO0.05
decreases by 45% [17] becausemore NO back diffuses towards
the alveoli and escapes into the blood and is withheld from
being exhaled. The increased NO diffusivity influences the
preacinar/acinar NO transport only and accordingly demon-
strates that a substantial part of FENO originates in the pre-
acinar/acinar zone. Thus bulk flow and back diffusion splits
the preacinar/acinar NO production.
The peripheral NO source (CANO), is the steady state
alveolar NO concentration that is a result of back diffusion
from intra acinar airways, NO production by the preacinar/
acinar cells and diffusion into the blood [13,16e22]. There is a
positive correlation between CANO and Ja´wNO or FENO0.05
[12,18] because acinar NO production contributes both to
CANO and Ja´wNO. The determination coefficient R2 Z 0.48
[12] indicates that about half of the variation of CANO can be
explained by variation of Ja´wNO or FENO0.05. If e.g. acinar NO
production increases both FENO0.05 (and Ja´wNO) and CANO
increase. For any given acinar airway NO production FENO0.05
(and Ja´wNO) and CANO exploits the same NO source and the
split is regulated by the balance between bulk flow in the
mouth direction and back diffusion towards the alveolar end.
The contribution of NO back diffusion to CANO may be esti-
mated and subtracted from CANO in order to estimate the
alveolar production, CANOcorrected [12,18].
Constriction and reduction of the crossectional area of
acinar airways may reduce back diffusion and result inincreased FENO [22,23]. Conversely dilatation e.g. by ste-
roid treatment, may decrease FENO [24] due to increased
back diffusion and disappearance into the blood. Thus
FENO0.05 and Ja´wNO are dependent on preacinar/acinar
airway NO production and back diffusion besides the pro-
duction in central conducting airways. Mere obstruction of
central conducting airways results in decreased FENO as
demonstrated by histamine provocation of normal subjects
[22]. The mechanisms are yet controversial.
Increased CANO during pollen season compared to out of
season was reported by Tufvesson et al. [25], whereas
CANO was not significantly different between out of season
and pollen season in a recent report by Lopez et al. in
similar subjects with seasonal asthma and allergic rhinitis
[26]. These two studies did, however, consider back diffu-
sion differently. Therefore, the purpose of the present
study has been to try to evaluate the effect of pollen sea-
son on acinar and alveolar involvement in pollen allergic
subjects with asthma and in healthy subjects by considering
the interdependence of FENO0.05 (or Ja´wNO) and CANO and
the effect of back diffusion.Methods
We recruited 13 pollen allergic non-smoking subjects with
mild-intermittent asthma aged between 26 and 61 years.
They were allergic to birch pollen as diagnosed by history
and presence of specific IgE against birch-pollen (Pharmacia
& Upjohn Diagnostics; Uppsala, Sweden) and were clinically
stable. They had no or mild symptoms out of pollen season.
Six of the subjects were taking inhaled glucocorticoids
regularly, and four of them in combination with long acting
b-2 stimulators, the others had only bronchodilators on
demand, i.e. particularly during season. Long acting b-2
stimulators where withheld for two days before the clinical
examination. 12 healthy non-smoking control subjects were
recruited. They were between 34 and 67 years, had no
history of lung disease and were on no medication. All
subjects were without respiratory tract infections within 3
weeks prior to the clinical test.
All subjects were examined during pollen season 2011,
i.e. between 2011-04-29 and 2011-06-02 and out of pollen
season either during the autumn 2010 or 2011. Birch pollen
levels during the pollen-season 2011 are illustrated in
Fig. 1.
Spirometry was performed according to ERS/ATS criteria
[27] and at each occasion before and after bronchodilata-
tion (3  0.5 mg nebulized Bricanyl; AstraZeneca; Sweden).
Predicted normal values were according to the ECCS/ERS
equations [28].
FENO was measured by a NIOX system (NIOX; Aerocrine
AB, Stockholm, Sweden) and was obtained before spirom-
etry and in duplicate at three exhalation flow rates within
10% of 50 mL/s (FENO0.05), 100 mL/s (FENO0.1) and
270 mL/s (FENO0.27). Measurements followed the ATS-ERS
guidelines and ensured a positive mouth pressure of at
least 5 cm H2O during exhalations. Plateau FENO values and
the corresponding exhalation flow rates were registered.
CANO and Ja´wNO were calculated according to Pietropaoli
et al. [9] and included FENO0.05. The effect of back
Figure 1 Pollen counts (count/m3) during the pollen season
2011 in Gothenburg.
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“true” alveolar concentration (CANOcorrected) was calcu-
lated [12]. FENO0.1 and FENO0.27 were not obtained during
season in one asthma subject.
The statistical analysis was performed using SAS (Sta-
tistical Analysis System, version 9.3; SAS Institute Inc.; NC,
USA) and Excel. Nonparametric two sided tests were used:
Wilcoxon exact test and Wilcoxon signed rank test of dif-
ferences between paired observations. Differences of
spirometric variables between seasons were tested by two
sided paired t-test.
The local ethics committee had approved of the protocol
and subjects signed an informed consent form.
Results
Individual results of subjects with asthma and mean data of
controls are presented in Table 1. Specific IgE against birchTable 1 Individual data of asthmatic patients and mean data of
DFVC and DFEV1 are the differences between post- and pre-bro
bronchodilatation values.
Asthmatics idnr
and controls
average
Specific
IgE, total
counts
Out of season
FVC (% pred) DFVC (%) FEV1 (% pred)
2 6.2 92 1.5 91
3 1.5 105 1.7 85
4 22 87 4.8 71
5 2.3 107 0.5 105
7 0.8 101 15.4 92
10 16 87 3.2 86
11 1.2 96 1.4 98
12 0.04 124 3.8 121
13 17.7 108 0.5 86
14 >100 108 0.2 108
15 39.2 110 0.2 110
16 6.8 106 3.7 102
17 2.4 100 8.0 75
Controls neg 109 1.0 104pollen varied considerably among the subjects with
asthma. Pollen season did not induce significant changes
neither in subjects with asthma nor in controls. Subjects
with asthma had on average close to normal spirometry
both out of season and during season and they were not
significantly different from controls regarding the forced
vital capacity (FVC) and the forced expired volume in 1 s
(FEV1). Effects of bronchodilatation (DFVC and DFEV1) were
rather small among both subjects with asthma and controls
but the subjects with asthma showed a slight but signifi-
cantly greater effect than controls during season.
FENO values are presented in Table 2. Subjects with
asthma exhaled substantially higher NO concentrations
during season compared to out of season whereas controls
are unaffected by season. Furthermore, subjects with
asthma exhaled higher NO concentrations compared to
controls at all three exhalation flows both out of season and
during season.
Ja´wNO, the acinar/alveolar NO concentration (CANO)
and CANOcorrected for back diffusion (CANOcorrected), are
presented in Table 3. Pollen exposure resulted in sub-
stantially increased Ja´wNO, unchanged CANO and reduced
CANOcorrected among subjects with asthma but had no sig-
nificant effects among controls. Furthermore, subjects
with asthma had significantly higher Ja´wNO compared to
controls irrespective of season as expected from the FENO
results. CANO was also higher among subjects with
asthma compared to controls irrespective of season.
CANOcorrected on the other hand was not significantly
different between subjects with asthma and controls
irrespective of season.
Fig. 2 illustrates the relationship between FENO0.05 and
CANO out of season and during season. The relationship is
particularly evident among subjects with asthma due to the
higher variability of FENO in this group. The relationship is
highly significant both out of season (adj R2 Z 0.86;
p < 0.0001) and during season (adj R2Z 0.74; p < 0.0001).
The regression equations arecontrols. Specific IgE against birch pollen and spirometry data.
nchodilatation values expressed as a percentage of the pre
Season
DFEV1 (%) FVC (% pred) DFVC (%) FEV1 (% pred) DFEV1 (%)
0.9 87 5.4 87 9.8
7.9 105 2.0 82 10.3
14.7 97 4.9 81 2.2
1.2 106 0.5 104 0
17.4 108 10.5 94 17.8
0.7 90 5.7 90 6.8
0.2 97 1.0 100 1.6
7.9 122 0.2 121 3.5
1.5 108 3.9 88 1.1
2.6 111 0.6 109 2.4
3.0 101 1.6 97 7.6
9.4 109 1.5 107 4.9
15.9 102 11.7 80 19.3
1.1 108 1.3 103 1.5
Table 2 Exhaled NO concentrations measured at constant
exhalation flows, 0.05, 0.1 and 0.27 L/s. Q1 and Q3 refer to
the first and third quantiles and p values refer to differ-
ences between autumn and spring.
Out of season Season p
Median Q1 Q3 Median Q1 Q3
Subjects with asthma
FENO0.05 (nL/L) 20.3 17.0 31.5 54.1 23.3 84.9 <0.001
FENO0.1 (nL/L) 13.1 10.6 19.0 22.1 1.5 68.6 0.02
FENO0.27 (nL/L) 7.5 5.7 8.4 9.6 5.9 35.4 0.007
Controls
FENO0.05 (nL/L) 13.4 11.1 17.7 15.6 10.3 20.0 0.62
FENO0.1 (nL/L) 8.9 6.2 10.4 9.2 6.3 12.5 0.85
FENO0.27 (nL/L) 5.1 4.1 5.8 4.2 3.5 5.9 0.52
1280 B. Bake et al.CANO (nL/L) Z 0.0787  FENO0.05 (nL/L) þ 1.70 out of
season
CANO (nL/L) Z 0.0507  FENO0.05 (nL/L) þ 2.02 pollen
season
Individual changes of FENO0.05 (DFENO0.05) and CANO
(DCANO) that develop between out of season and season,
i.e. season e out of season, are demonstrated in Fig. 3.
There are rather small differences between seasons among
almost all controls (with one exception) and the majority of
the subjects with asthma. Comparatively large effects of
pollen season are observed in four subjects with asthma.
The relationship between DFENO0.05 and DCANO is highly
significant (adj R2 Z 0.56; p < 0.0001) and the regression
equation is
DCANO (nL/L) Z 0.0556  DFENO0.05 (nL/L)  0.49Table 3 Estimated maximal flux of NO from airways
(Ja´wNO), alveolar NO concentration (CANO) and CAN-
Ocorrected for back diffusion (CANOcorrected). Q1 and Q3 refer
to the first and third quantiles and p values refer to dif-
ferences between autumn and spring.
Out of pollen season Pollen season p
Median Q1 Q3 Median Q1 Q3
Subjects with asthma
Ja´wNO (nL/s) 0.84S 0.66 1.49 1.84S 0.94 5.69 0.001
CANO (nL/L) 3.51S 2.87 4.33 4.67S 2.67 8.07 0.68
CANOcorrected
(nL/L)
1.61NS 1.44 2.31 1.01NS 0.33 2.00 0.012
Controls
Ja´wNO (nL/s) 0.53 0.43 0.75 0.72 0.40 0.87 0.27
CANO (nL/L) 2.60 2.08 3.25 2.09 1.55 3.36 0.38
CANOcorrected
(nL/L)
1.61 1.15 2.30 1.14 0.77 2.11 0.27
p values are two sided Wilcoxon signed rank of differences
between season and out of season.
S and NS denotes a significantly/non-significantly higher value
for subjects with asthma compared to controls (one sided Wil-
coxon exact test).Numeric results regarding the four subjects with asthma
and the one control that developed comparatively large
changes as an effect of pollen season are presented in
Table 4. There are large inter individual differences:
DFENO0.05 ranges from 0.6e7.2 nL/s and DCANO from
5.3e9.2 nL/L.
Discussion
The present study showed that birch pollen allergic sub-
jects with asthma have on average significantly higher
FENO0.05, Ja´wNO and CANO than controls and that during
pollen season FENO0.05 and Ja´wNO increase, CANO is not
significantly affected and CANOcorrected decreases. Individ-
ual results show, however, that CANO increases substan-
tially in a few subjects with asthma. FENO among controls
are not affected by season.
The pollen-season 2011 was characterized by a high peak
of birch pollen in the end of April, where the levels were
2800 counts/m3, and remained significantly elevated for
more than two weeks. Exposure to pollen from trees, like
birch, above 15 per m3 is likely to give rise to symptoms in
many sensitized subjects and levels > 90 have beenFigure 2 The relationship between airway NO production
(FENO0.05) and acinar/alveolar nitric oxide concentration
(CANO) uncorrected for back-diffusion out of pollen season and
during pollen season.
Figure 3 Individual changes of FENO0.05 (DFENO0.05) and
CANO (DCANO) that developed between out of season and
pollen season.
Effects of pollen season on nitric oxide production 1281described to induce symptoms in most subjects [29], i.e. an
effect is described at substantially lower levels than the
exposure of the subjects in the present study. It is well
known that respiratory symptoms from the lower airways
often lag for two days or more after exposure, and that
repeated pollen exposure, also at lower levels, increase the
symptomatology due to priming of the mucosa [29]. The
individual exposure levels are not known in the present
study, and may vary considerably. Highly sensitized persons
in particular may choose to stay indoors to reduce expo-
sure. Nevertheless FENO increased during pollen-season in
all sensitized subjects, indicating sufficient exposure to
give rise to eosinophilic airway inflammation.
FENO0.05 was increased out of season and increased
further during season among subjects with asthma whereas
controls remained unaffected (Table 2). This is in line with
the results of many previous publications [1,2,4,7,30] and
indicates that pollen exposure build up eosinophilic airway
inflammation in pollen allergic subjects with asthma but
not in controls. This is in line also with results summarized
by Tilles et al., showing increased bronchial reactivity
during pollen season among allergic subjects with asthma
[31]. The likely interpretation in view of the normal FEV1, is
that the increased NO does not originate from the most
central airway generations. Obstruction of these central
airways would have been associated with a decrease of
FEV1, whereas obstruction of more peripheral airwayTable 4 Individual results of the four subjects with asthma and
effects of pollen season.
Idnr Asth/Contr FENO0.05 (nL/s) CANO (nL/L)
Out of season Season D Out of season S
10 Asth 28 75 48 4.3
14 Asth 32 179 147 3.3
15 Asth 28 155 127 3.5 1
17 Asth 144 152 8 12.3
22 Contr 34 26 9 3.1generations may not [32]. An alternative explanation could
be that the increased formation of NO in central airways
does not necessarily cause airway obstruction. Anyhow,
FENO measurements are evidently superior to spirometry
regarding the detection of allergic airway inflammation.
The axial distribution of airway NO production in sub-
jects with asthma during and out of pollen season is,
however, not clearly delineated. Ja´wNO increased signifi-
cantly whereas CANO remained unaffected by season
among the subjects with asthma in the present study (Table
3). Tufvesson et al. found significantly increased CANO
during season compared to out of season in rhinitic subjects
with asthma [25]. Ja´wNO increased in both studies. Tuf-
vesson et al. investigated 13 rhinitic subjects with asthma
during season and out of season whereof 11 subjects
showed an increased CANO and 2 subjects a decreased
CANO during season whereas in the present study 7 subjects
showed an increased CANO and 5 subjects a decreased
CANO during season. Thus the difference in CANO results is
moderate. The degree of airway obstruction was not re-
ported in the study by Tufvesson et al. [25]. Spirometry was
normal and did not change during season in the present
study (Table 1). If the subjects of Tufvesson et al. became
more obstructive during season this might explain the
discrepancy regarding CANO. Tufvesson et al. used FENO
obtained at 100 mL/s and 400 mL/s and the model of
Tsoukias et al. for the calculation of CANO [10]. Applying
that model and flows of 100 mL/s and 270 mL/s to the
present material resulted in CANO Z 3.31 nL/L and
3.16 nL/L in asthma subjects out of season and during
season respectively. Thus the different methods do not
explain the different results. Different characters of sub-
jects with asthma appear to be the most likely reason for
the moderate difference of CANO results between the
present and that of Tufvesson et al. In the very recent
report by Lopez et al. 20 subjects with allergic rhinitis, 11
subjects with asthma and allergic rhinitis and 11 controls
were studied [26]. In the asthma group there were no sig-
nificant effects of pollen season on either Ja´wNO or CANO
whereas in subjects with allergic rhinitis Ja´wNO increased
significantly during pollen season but CANO was not
affected. Thus, in line with the present results CANO ap-
pears to be unaffected by pollen season. The unchanged
Ja´wNO among subjects with asthma in the study by Lopez
et al. is probably due to the substantially increased values
out of season compared to controls: 2.27 pL/s compared to
0.60 pL/s. In the present study the corresponding results
were 0.84 pL/s compared to 0.53 pL/s (Table 3). Inthe one control that deviates from majority by showing large
FEV% Delta FEV1 (L)
eason D Out of season Season Out of season Season
7.4 3.1 86 88 0.0 0.2
9.1 5.8 83 82 0.1 0.1
2.7 9.2 82 78 0.2 0.3
7.0 5.3 65 68 0.4 0.5
6.8 3.7 80 82 0.0 0.0
1282 B. Bake et al.summary we consider the present and the studies of Tuf-
vesson et al. and Lopez et al. [25,26] to indicate that
Ja´wNO increase during season whereas CANO may increase
depending on the characteristics of the subjects with
asthma.
How then to interpret the axial distribution of NO pro-
duction in view of increased Ja´wNO, FENO0.05 and CANO in
allergic subjects with asthma out of season and during
season? In a recent letter to the editor, Verbanck et al.
suggested that the relationship between Ja´wNO or FENO0.05
and CANO provides information about alveolar production
and impeded back diffusion [33]. CANO as a function of
FENO0.05 out of season (Fig. 1 upper panel) shows that on
average CANO increase by 0.0787  FENO0.05. Kerckx et al.
showed by consentient model experiments and measure-
ments that CANO increases by 0.075  FENO0.05 [12]. Thus,
the higher CANO among subjects with asthma compared to
controls (Table 3) appears to be due entirely to increased
NO production in the preacinar/acinar airways and does not
imply increased alveolar production. CANO as a function of
FENO0.05 during pollen season shows that on average CANO
increased by 0.0507  FENO0.05 in the present study (Fig. 1
lower panel). The 95% confidence interval of the FENO0.05/
CANO slope is 0.049e0.150 [24]. Thus, the less steep slope
between CANO and FENO0.05 during season may be due to
impeded back diffusion caused by constriction of acinar
airways and brought about by pollen exposure induced
inflammation. This interpretation is, however, dependent
on the assumption that the substantially increased FENO0.05
during season is due to elevated NO flux from preacinar/
acinar airways. Had the substantially increased FENO0.05
during season been due primarily to elevated NO flux from
the most central airways then CANO would not depend on
FENO0.05. The interpretation regarding impeded back
diffusion and constriction of preacinar/acinar airways could
therefore possibly be incorrect. Anyhow, involvement of
the most distal and smallest airways in asthma has been
demonstrated by multiple breath washout [34e36] sup-
porting the interpretation that acinar airways are indeed
affected in asthma causing ventilation heterogeneity. In
addition, the present spirometric results are compatible
with effects on peripheral airways of pollen exposure as
there was no evidence of effects on central airways despite
the substantially increased Ja´wNO.
When the estimated effect of back diffusion from acinar
airways to alveoli had been subtracted from CANO the
resulting CANOcorrected decreased significantly during pollen
season in subjects with asthma. It is unlikely that NO pro-
duced by the alveolar cells would decrease during pollen
season. It seems more likely that the back diffusion
correction is inappropriate. Indeed Tufvesson et al.
observed that when CANO was corrected for back diffusion
several rhinitic subjects with high Ja´wNO got negative
CANOcorrected, i.e. unrealistic values [25]. A possible
explanation has been suggested by Verbanck et al. i.e. the
calculated effect of back diffusion is erroneously over-
estimated because of constriction of intra acinar airways
reducing the available total cross sectional area and
thereby impeding back diffusion [22]. Accordingly one may
conclude that pollen sensitized subjects with asthma may
develop intra acinar airway obstruction during pollen sea-
son. Then Ja´wNO would be expected to increase as less NOis lost to the blood and more NO is being exhaled. This is in
line with the results of the present study and could
contribute to the increased FENO0.05 and Ja´wNO in subjects
with asthma during pollen season.
Individual changes during pollen season, i.e. DFENO0.05
or DJa´wNO and DCANO show that despite of no significant
effect of season on CANO in subjects with asthma in general
there appears to be a relationship between DFENO0.05 and
DCANO when the three subjects with asthma with sub-
stantial changes are considered (Fig. 3 and Table 4). Pre-
sumably the asthma group is composed of subjects with
different characteristics. The average quotient DCANO/
DFENO0.05 of these three subjects with asthma is 0.059 i.e.
close to the lower end of the 95% confidence interval [24]
and consistent with the notion of impeded back diffusion
and constriction of intra acinar airways. This interpretation
is consistent also with the obtained negative DCANOcorrected
and the unrealistic negative CANOcorrected during pollen
season in two of the subjects with asthma. The majority of
the subjects with asthma showed small increases of
FENO0.05 but no systematic changes of CANO and therefore
presumably unaffected NO production in the preacinar/
acinar airways and no constriction of intra acinar airways.
The limitations of the present study are above all the
limited number of subjects with asthma. FENO was
measured at three flows only and e.g. five flows between 70
and 300 mL/s would have been preferable, ensuring valid
regressions of the “slope intercept method”. It had of
course been favorable to have measured nitrogen multiple
breath washout also to get independent information on
individual effects of pollen season on acinar involvement.
We conclude regarding allergic subjects with mild
asthma 1) that out of pollen season many but not all suffer
from airway inflammation including acinar/preacinar air-
ways but normal alveolar production, 2) that exposure to
birch pollen induces increased airway inflammation in
almost all subjects with asthma sensitized to pollen, 3) that
exposure to birch pollen may induce obstruction of intra
acinar airways but unaffected alveolar production in a mi-
nority of subjects. Furthermore, FENO measurements are
far superior to ordinary spirometry to detect changes in
pollen allergic asthmatic subjects.Conflict of interest
None declared.References
[1] Baraldi E, Carra S, Dario C, Azzolin N, Ongaro R, Marcer G,
et al. Effect of natural grass pollen exposure on exhaled ni-
tric oxide in asthmatic children. Am J Respir Crit Care Med
1999;159:262e6.
[2] Bergmann-Hug K, Wirth R, Henseler M, Helbling A,
Pichler WJ, Schnyder B. Effect of natural seasonal pollen
exposure and repeated nasal allergen provocations on
elevation of exhaled nitric oxide. Allergy 2009;64:1629e34.
[3] Gratziou C, Rovina N, Lignos M, Vogiatzis I, Roussos C.
Exhaled nitric oxide in seasonal allergic rhinitis: influence of
pollen season and therapy. Clin Exp Allergy e J Br Soc Allergy
Clin Immunol 2001;31:409e16.
Effects of pollen season on nitric oxide production 1283[4] Henriksen AH, Sue-Chu M, Holmen TL, Langhammer A,
Bjermer L. Exhaled and nasal no levels in allergic rhinitis:
relation to sensitization, pollen season and bronchial
hyperresponsiveness. Eur Respir J e Off J Eur Soc Clin Respir
Physiol 1999;13:301e6.
[5] Olin AC, Alving K, Toren K. Exhaled nitric oxide: relation to
sensitization and respiratory symptoms. Clin Exp Allergy e J
Br Soc Allergy Clin Immunol 2004;34:221e6.
[6] Silkoff PE, Lent AM, Busacker AA, Katial RK, Balzar S,
Strand M, et al. Exhaled nitric oxide identifies the persistent
eosinophilic phenotype in severe refractory asthma. J Allergy
Clin Immunol 2005;116:1249e55.
[7] Vahlkvist S, Sinding M, Skamstrup K, Bisgaard H. Daily home
measurements of exhaled nitric oxide in asthmatic children
during natural birch pollen exposure. J Allergy Clin Immunol
2006;117:1272e6.
[8] Ciebiada M, Cichocki P, Kasztalska K, Majewski S, Gorska-
Ciebiada M, Gorski P. Orally exhaled nitric oxide in patients
with seasonal allergic rhinitis during natural pollen season.
Am J Rhinol Allergy 2012;26:e32e6.
[9] Pietropaoli AP, Perillo IB, Torres A, Perkins PT, Frasier LM,
Utell MJ, et al. Simultaneous measurement of nitric oxide
production by conducting and alveolar airways of humans. J
Appl Physiol 1999;87:1532e42.
[10] Tsoukias NM, George SC. A two-compartment model of pul-
monary nitric oxide exchange dynamics. J Appl Physiol 1998;
85:653e66.
[11] Silkoff PE, McClean PA, Slutsky AS, Furlott HG, Hoffstein E,
Wakita S, et al. Marked flow-dependence of exhaled nitric
oxide using a new technique to exclude nasal nitric oxide.
Am J Respir Crit Care Med 1997;155:260e7.
[12] Kerckx Y, Michils A, Van Muylem A. Airway contribution to
alveolar nitric oxide in healthy subjects and stable asthma
patients. J Appl Physiol 2008;104:918e24.
[13] Kerckx Y, Van Muylem A. Axial distribution heterogeneity of
nitric oxide airway production in healthy adults. J Appl
Physiol 2009;106:1832e9.
[14] Silkoff PE, McClean PA, Caramori M, Slutsky AS, Zamel N. A
significant proportion of exhaled nitric oxide arises in large
airways in normal subjects. Respir Physiol 1998;113:33e8.
[15] Weibel ER. Morphometry of the human lung. Berlin Go¨ttingen
Heidelberg: Springer Verlag; 1963.
[16] Van Muylem A, Noel C, Paiva M. Modeling of impact of gas
molecular diffusion on nitric oxide expired profile. J Appl
Physiol 2003;94:119e27.
[17] ShinHW,Condorelli P, Rose-GottronCM,CooperDM,George SC.
Probing the impact of axial diffusion on nitric oxide exchange
dynamics with heliox. J Appl Physiol 2004;97:874e82.
[18] Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A
simple technique to characterize proximal and peripheral
nitric oxide exchange using constant flow exhalations and an
axial diffusion model. J Appl Physiol 2007;102:417e25.
[19] Shin HW, Condorelli P, George SC. A new and more accurate
technique to characterize airway nitric oxide using different
breath-hold times. J Appl Physiol 2005;98:1869e77.
[20] Shin HW, Condorelli P, George SC. Examining axial diffusion
of nitric oxide in the lungs using heliox and breath hold. J
Appl Physiol 2006;100:623e30.[21] Shin HW, George SC. Impact of axial diffusion on nitric oxide
exchange in the lungs. J Appl Physiol 2002;93:2070e80.
[22] Verbanck S, Kerckx Y, Schuermans D, Vincken W, Paiva M,
Van Muylem A. Effect of airways constriction on exhaled ni-
tric oxide. J Appl Physiol 2008;104:925e30.
[23] Keen C, Olin AC, Wennergren G, Gustafsson P. Small airway
function, exhaled no and airway hyper-responsiveness in
paediatric asthma. Respir Med 2011;105:1476e84.
[24] Van Muylem A, Kerckx Y, Michils A. Acinar effect of inhaled
steroids evidenced by exhaled nitric oxide. J Allergy Clin
Immunol 2010;126:730e5.
[25] Tufvesson E, Aronsson D, Ankerst J, George SC, Bjermer L.
Peripheral nitric oxide is increased in rhinitic patients with
asthma compared to bronchial hyperresponsiveness. Respir
Med 2007;101:2321e6.
[26] Lopez V, Prieto L, Perez-Frances C, Barato D, Marin J. Nat-
ural pollen exposure increases the response plateau to
adenosine 5’-monophosphate and bronchial but not alveolar
nitric oxide in sensitized subjects. Respir e Int Rev Thorac
Dis 2012;83:225e32.
[27] Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R,
Coates A, et al. Standardisation of spirometry. Eur Respir J e
Off J Eur Soc Clin Respir Physiol 2005;26:319e38.
[28] Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R,
Yernault JC. Lung volumes and forced ventilatory flows.
Report working party standardization of lung function tests,
European community for steel and coal. Official statement of
the European respiratory society. Eur Respir J Suppl 1993;16:
5e40.
[29] Frenz DA. Interpreting atmospheric pollen counts for use in
clinical allergy: spatial variability. Ann Allergy Asthma
Immunol e Off Publ Am Coll Allergy Asthma Immunol 2000;
84:481e9 [quiz 9e91].
[30] Skiepko R, Zietkowski Z, Tomasiak-Lozowska MM,
Tomasiak M, Bodzenta-Lukaszyk A. Bronchial hyper-
responsiveness and airway inflammation in patients with
seasonal allergic rhinitis. J Investig Allergol Clin Immunol e
Off Organ Int Assoc Asthmol 2011;21:532e9.
[31] Tilles SA, Bardana Jr EJ. Seasonal variation in bronchial hy-
perreactivity (bhr) in allergic patients. Clin Rev Allergy
Immunol 1997;15:169e85.
[32] Mead J. The lung’s “quiet zone”. N Engl J Med 1970;282:
1318e9.
[33] Verbanck S, Malinovschi A, George S, Gelb AF, Vincken W,
Van Muylem A. Bronchial and alveolar components of exhaled
nitric oxide and their relationship. Eur Respir J e Off J Eur
Soc Clin Respir Physiol 2012;39:1258e61.
[34] Thompson BR, Douglass JA, Ellis MJ, Kelly VJ, O’Hehir RE,
King GG, et al. Peripheral lung function in patients with
stable and unstable asthma. J Allergy Clin Immunol 2013;131:
1322e8.
[35] Verbanck S, Schuermans D, Noppen M, Van Muylem A,
Paiva M, Vincken W. Evidence of acinar airway involve-
ment in asthma. Am J Respir Crit Care Med 1999;159:
1545e50.
[36] Verbanck S, Schuermans D, Vincken W. Inflammation and
airway function in the lung periphery of patients with stable
asthma. J Allergy Clin Immunol 2010;125:611e6.
